Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01629862 · ClinicalTrials.gov registry record · Phase 2

Vascular Impairment in Type II Diabetes Mellitus With Co-morbid Obstructive Sleep Apnea

A Phase 2 study, sponsored by Sanjay R Patel.

Completed
Registry status
Phase 2
Development phase
53
Enrollment target

NCT01629862 is a Phase 2 study that has completed, run by Sanjay R Patel. The registered enrollment target is 53 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01629862, a Phase 2 study, has completed, sponsored by Sanjay R Patel.

COMPLETED
Registry status
Phase 2
Development phase
53 participants
Enrollment target

Study Summary

The investigators will examine the possible synergistic effects of obstructive sleep apnea (OSA) and type II diabetes mellitus (DM) on vascular functioning by performing a two-part investigation: * A cross-sectional study comparing subjects with OSA+DM, OSA only, DM only, and healthy controls. * A three-month randomized placebo-controlled trial of continuous positive airway pressure (CPAP) in subjects with OSA+DM.

Interventions

  • DEVICE Continuous positive airway pressure
  • DEVICE Sham continuous positive airway pressure

Trial Details

FieldValue
Enrollment Target 53 participants
Start Date 2012-04
Est. Completion 2017-02
Phase Phase 2

Sponsor

Sanjay R Patel

2 total trials

What the Registry Record Tells You About NCT01629862

The ClinicalTrials.gov registry entry for NCT01629862 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sanjay R Patel, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Continuous positive airway pressure is the first listed.

NCT01629862 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01629862 about?

NCT01629862 is a clinical study titled "Vascular Impairment in Type II Diabetes Mellitus With Co-morbid Obstructive Sleep Apnea". The investigators will examine the possible synergistic effects of obstructive sleep apnea (OSA) and type II diabetes mellitus (DM) on vascular functioning by performing a two-part investigation: * A cross-sectional study comparing subjects with OSA+DM, OSA only, DM only, and healthy controls. * A ...

What is the current status of trial NCT01629862?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 53 participants. The study started on 2012-04. Estimated completion is 2017-02.

What interventions are being tested in trial NCT01629862?

The interventions under investigation include: Continuous positive airway pressure (DEVICE), Sham continuous positive airway pressure (DEVICE).

Who is sponsoring clinical trial NCT01629862?

This trial is sponsored by Sanjay R Patel, which has 2 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.